Montclair, NJ ― June 13, 2018 ― Jack Mycka, Global President and CEO of MME, LLC, will join with Manny Papadimitropoulos, MScPhm, Ph.D. (Health Outcomes Scientific Leader, Latin America, Eli Lilly, and Adjunct Assistant Professor, Faculty of Pharmacy, University of Toronto), and Shanlian Hu, MD, MSc (Senior Consultant, Shanghai Health Development Research Center), to offer two short courses at ISPOR Asia Pacific 2018, to be held in Tokyo, Japan, September 8-11.
Elements of Pharmaceutical/Biotech Pricing I will give participants a basic understanding of the key terminology and issues involved in pricing decisions and the principles of market access. It covers the tools to document product value, the role of pharmacoeconomics, and the differences in payment systems that help to shape pricing decisions. Recent pharmaceutical spending patterns, trends, and cost-containment measures will also be discussed, taking into account the wider policy context. The health systems approach in several countries will be presented.
Case Studies in Pharmaceutical/Biotech Pricing II – Advanced will employ case studies to lead participants through the key steps of new product pricing, with focus on the need to thoroughly analyze the business environment and its constraints and opportunities, and the need to closely integrate the pricing, reimbursement, and pharmacoeconomic strategy for the new product with the clinical development and marketing strategies. Practical exercises will allow participants to consolidate the concepts delivered in the “Elements” introductory session and expanded here. Areas covered will include the post-launch issues of reimbursement and pricing maintenance as a part of life-cycle management in a global environment.
For more information on the conference, please visit the ISPOR Web site.
For additional information about this course or Medical Marketing Economics, please contact us at +1 662.281.0502 or via e-mail at info@m2econ.com.
